Cancer News and Research

Latest Cancer News and Research

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Dr. Paul Fidel, the Carl Baldridge Professor and Associate Dean for Research at LSU Health Sciences Center New Orleans' School of Dentistry, is the lead principal investigator of a $2.76 million grant from the National Institute of Dental and Craniofacial Research over five years to study how HIV and antiretroviral therapy may change communities of bacteria in the mouth and what effects those changes may have on oral infections in HIV disease.

8 Oct 2013

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Chemists at The Scripps Research Institute (TSRI) have devised a new technique for connecting drug molecules to antibodies to make advanced therapies.

8 Oct 2013

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

7 Oct 2013

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Immutep S.A., the biopharmaceutical company specializing in immuno-oncology, and Eddingpharm have entered into an agreement regarding the development, commercialization and manufacturing of Immutep’s ImmuFact IMP321.

7 Oct 2013

A*STAR, Debiopharm Team Up To Develop Epigenetic Cancer Target

...

7 Oct 2013

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

7 Oct 2013

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that a Services Agreement has been signed with the German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen (GRCBDS) whereby GRCBDS will provide pharmaceutical development and GMP manufacturing services for Kiadis Pharma's ongoing Phase II clinical study with ATIR™.

7 Oct 2013

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to six prominent surgeons from Germany, England, Thailand, Mexico, and Malaysia during the Convocation ceremony that preceded the official opening of the 2013 Clinical Congress of the American College of Surgeons.

7 Oct 2013

Researchers discover how cancer development molecule maintains its genome integrity

University of Montreal researchers have discovered how telomerase, a molecule essential for cancer development, is directed to structures on our genome called telomeres in order to maintain its integrity and in turn, the integrity of the genome.

7 Oct 2013

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.

7 Oct 2013

Newly discovered compound could be developed as antifungal drug to treat fungal infections

On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult and expensive.

7 Oct 2013

State highlights: Wendy Davis announces Texas gubernatorial run; Calif. gov. signs pharmacist scope-of-practice bill

Wendy Davis, the Democratic state senator whose abortion filibuster catapulted her to national fame, announced Thursday that she will run for Texas governor, a race that looks to be a banner 2014 contest (Glueck, 10/4).

7 Oct 2013

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

With the completion of the first genome-wide association study for Sj-gren's syndrome, an international coalition of researchers led by scientists at the Oklahoma Medical Research Foundation has identified six new disease-related genes.

7 Oct 2013

Winners of VCCircle Healthcare Awards announced

The event recognised medical professionals who have not only scaled in terms of clinical and financial performance but also played a role in making a difference in patients' lives.

7 Oct 2013

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.

7 Oct 2013

Research: VIP interneurons inhibit activation of other inhibitory neurons in cerebral cortex

The cerebral cortex contains two major types of neurons: principal neurons that are excitatory and interneurons that are inhibitory, all interconnected within the same network.

7 Oct 2013

New study highlights that physicians prefer topical therapies for actinic keratosis

Over 90 per cent of physicians treating actinic keratosis (AK) prefer short duration treatment options with fast resolving local skin responses (LSRs), is the finding of a global study (‘Physician Perceptions and Experience of Current Treatment in Actinic Keratosis’) that is being presented today at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV).

5 Oct 2013

Research roundup: Health law's effects on consumer spending; Mass. experience finds increased use of laparoscopic surgery

The authors find that average out-of-pocket spending is expected to decrease for all groups considered in the analysis, although decreases in out-of-pocket spending will be largest for those who would otherwise be uninsured.

5 Oct 2013

Opinions on shutdown: Both sides have moved to indefensible positions; health law is not 'settled,' finding a 'non-disastrous' debt deal

Acrimony, insults, the government shut down. Time to talk to a wise man, someone from the days when government worked. I turned to the famous Mr. Baker - James A. Baker III. ... The Republicans made a mistake early on with a "maximalist" position on Obamacare - they could not realistically achieve their aim of defunding when the Democrats hold the White House and Senate. But the president's position is a "pretty damn maximalist position itself, and people will say that" (Peggy Noonan, 10/3).

5 Oct 2013

Boreal Genomics announces completion of $18 million Series C financing round

Boreal Genomics, a privately held provider of technology for non-invasive genomic profiling of tumors from blood plasma of cancer patients, announced today the completion of an $18 million Series C financing round.

5 Oct 2013

Cancer News and Research

Latest Cancer News and Research

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

A*STAR, Debiopharm Team Up To Develop Epigenetic Cancer Target

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Researchers discover how cancer development molecule maintains its genome integrity

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Newly discovered compound could be developed as antifungal drug to treat fungal infections

State highlights: Wendy Davis announces Texas gubernatorial run; Calif. gov. signs pharmacist scope-of-practice bill

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

Winners of VCCircle Healthcare Awards announced

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

Research: VIP interneurons inhibit activation of other inhibitory neurons in cerebral cortex

New study highlights that physicians prefer topical therapies for actinic keratosis

Research roundup: Health law's effects on consumer spending; Mass. experience finds increased use of laparoscopic surgery

Opinions on shutdown: Both sides have moved to indefensible positions; health law is not 'settled,' finding a 'non-disastrous' debt deal

Boreal Genomics announces completion of $18 million Series C financing round

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in